Results 311 to 320 of about 274,716 (345)
Some of the next articles are maybe not open access.
European Journal of Neurology, 2019
Parkinson disease (PD) is the most common neurodegenerative movement disorder. In Europe, prevalence and incidence rates for PD are estimated at approximately 108–257/100 000 and 11–19/100 000 per year, respectively. Risk factors include age, male gender and some environmental factors.
R, Balestrino, A H V, Schapira
openaire +4 more sources
Parkinson disease (PD) is the most common neurodegenerative movement disorder. In Europe, prevalence and incidence rates for PD are estimated at approximately 108–257/100 000 and 11–19/100 000 per year, respectively. Risk factors include age, male gender and some environmental factors.
R, Balestrino, A H V, Schapira
openaire +4 more sources
Parkinson's disease, Parkinsonism and aging
Archives of Gerontology and Geriatrics, 2002NICITA MAURO, Vittorio +5 more
openaire +3 more sources
Inflammation and immune dysfunction in Parkinson disease
Nature Reviews Immunology, 2022Malú Gámez Tansey +2 more
exaly
2013
In advanced Parkinson's disease (PD), the emergence of symptoms refractory to conventional therapy poses therapeutic challenges. The success of deep brain stimulation (DBS) and advances in the understanding of the pathophysiology of PD have raised interest in noninvasive brain stimulation as an alternative therapeutic tool.
openaire +2 more sources
In advanced Parkinson's disease (PD), the emergence of symptoms refractory to conventional therapy poses therapeutic challenges. The success of deep brain stimulation (DBS) and advances in the understanding of the pathophysiology of PD have raised interest in noninvasive brain stimulation as an alternative therapeutic tool.
openaire +2 more sources
Parkinson disease-associated cognitive impairment
Nature Reviews Disease Primers, 2021Dag Aarsland +2 more
exaly